Trial NCT05205759

View at ClinicalTrials.gov 
Org. Study IDs: MANTICO
Secondary IDs: 2021-002612-31

Last trial update was posted on 2022-07-26

MeSH Interventions

Bamlanivimab Casirivimab and imdevimab drug combination Sotrovimab

MeSH Conditions

COVID-19

Other Conditions


Stopping Reasons

Stop for futility after the onset of the omicron wave

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID